Left Continue shopping
Your Order

You have no items in your cart

Professional Supplements & Nutritional Products Since 1998

Over 30 years of clinical research supports the effectiveness of the 2 patented probiotic bacterial strains in Fem-Dophilus®.* These beneficial strains populate the vaginal tract with healthy bacteria to balance the vaginal microbiome and help maintain a healthy vaginal and urinary tract.* These two strains are the most clinically published strains for vaginal health worldwide**, and were carefully selected due to their effectiveness in these studies.

Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival in the lower intestine.*

GR-1®/RC-14® and VAGINAL FLORA (also called microbiota) In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

  • Maintains and balances vaginal microbiome and urinary tract health* with GR-1® & RC-14® strains*, 2 clinically effective strains
  • A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid, enhances probiotic bacterial survival in the lower intestine, and into the vaginal tract.*
  • The package contains a smaller, Activ-Vial™ moisture-controlled desiccant bottle for better stability of probiotic bacteria
  • In one randomized clinical trial, 82% of women studied had healthy vaginal flora after 28 days of use at 1.6 billion CFU per day of a probiotic (formulated with L. rhamnosus, GR-1® and L. reuteri, RC-14®) compared to 50% before supplementation. Whereas in the control group (taking 10 billion CFU of common strain, L. rhamnosus GG) there was no improvement in the percentage of women with healthy vaginal flora.¹
  • 5 Billion CFU Per Serving
  • Vegan, Non-GMO, Gluten Free
  • Keep Refrigerated
  • Reid et al. (2001). FEMS Immunol. Med. Microbiol.

Suggested Use:

Adults take 1 capsule once a day. May be taken with or without food. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.

Other Ingredients:

Maltodextrin, capsule (hydroxypropylmethylcellulose, titanium dioxide [color]), microcrystalline cellulose, and magnesium stearate (vegetable source).

No wheat, gluten, soybeans, dairy, egg, fish/shellfish, peanuts/tree nuts or sesame.

§ Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.

GR-1 and RC-14 are registered trademarks of Chr. Hansen A/S.

Strains Matter™: Jarrow Formulas’ Probiotics Contain Clinically Documented Strains.

Warning:

Consult a healthcare professional before using this product if you are pregnant, nursing, under the age of 18, are taking medication, or have a medical condition; if adverse reactions occur, discontinue use.

Keep out of the reach of children.

Keep refrigerated.